Camden National Corp. (CAC)

NASDAQFinancialsBanks - RegionalSnapshot 2026-10-23

$57.84-0.03%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Camden National Corp.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	68.88M
EPS	—	1.396
Annual ending 2026-12-31
Revenue	—	269.48M
EPS	—	5.38
Annual ending 2027-12-31
Revenue	—	283.27M
EPS	—	5.74

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Maintain quarterly dividend at $0.42 per share	Camden National keeps paying a steady dividend of $0.42 per share each quarter.	Intact	quarterly dividend falls below $0.42 per share	Dividend per share: $0.42 per share FY2026-Q2; GAAP. Published target: >=0.42 USD per share quarterly. Target period is not explicitly aligned with this observation. Source published Aug 6, 20260.42 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 1871e656-1bf9-4081-a0b4-38c107bc7b60. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated in 3 of last 3 quarters. The company consistently declared a quarterly dividend of $0.42 per share in Q1, Q2, and Q3 2026. This reflects steady capital allocation to shareholders as committed. Delivery assessment Oct 24, 2026
Achieve EPS of at least $4.39 in 2026	A primary condition in Camden National Corp.'s published investment case. The stated target is >=4.39 USD per share.	Intact	EPS guidance falls below $4.39 for 2026	Diluted EPS: $1.35 per share FY2026-Q2; GAAP. Published target: >=4.39 USD per share. Target period is not explicitly aligned with this observation. Source published Aug 6, 20261.35 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 1871e656-1bf9-4081-a0b4-38c107bc7b60. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Limit revenue decline to no worse than -5% in next 12 months	A supporting condition in Camden National Corp.'s published investment case. The stated target is >=-5% YoY revenue growth.	Improving	revenue decline exceeds -5% YoY	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Complete share buyback of up to 850,000 shares (~5% of shares)	It has a share buyback plan for up to 5% of shares.	Intact	buyback program is canceled or materially reduced	Required source inputs unavailable Cannot calculate Share repurchases from the available matching source inputs. Missing inputs are not treated as zero. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS: comparable history unavailable.

FY2027 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	Unavailable	Unavailable	4 / 2
2026-07-25	Unavailable	Unavailable	4 / 2
2026-07-26	Unavailable	Unavailable	4 / 2
2026-07-27	Unavailable	Unavailable	4 / 2
2026-07-28	Unavailable	Unavailable	4 / 2
2026-07-29	Unavailable	Unavailable	4 / 2
2026-07-30	Unavailable	Unavailable	4 / 2
2026-07-31	Unavailable	Unavailable	3 / 2
2026-08-01	Unavailable	Unavailable	4 / 2
2026-08-02	Unavailable	Unavailable	4 / 2
2026-08-03	Unavailable	Unavailable	4 / 2
2026-08-04	Unavailable	Unavailable	4 / 2
2026-08-05	Unavailable	Unavailable	4 / 2
2026-08-06	Unavailable	Unavailable	4 / 2
2026-08-07	Unavailable	Unavailable	3 / 2
2026-08-08	Unavailable	Unavailable	4 / 2
2026-08-09	Unavailable	Unavailable	4 / 2
2026-08-10	Unavailable	Unavailable	4 / 2
2026-08-11	Unavailable	Unavailable	3 / 2
2026-08-12	Unavailable	Unavailable	3 / 2
2026-08-13	Unavailable	Unavailable	3 / 2
2026-08-14	Unavailable	Unavailable	3 / 2
2026-08-15	Unavailable	Unavailable	3 / 2
2026-08-16	Unavailable	Unavailable	3 / 2
2026-08-17	Unavailable	Unavailable	3 / 2
2026-08-18	Unavailable	Unavailable	3 / 2
2026-08-19	Unavailable	Unavailable	3 / 2
2026-08-20	Unavailable	Unavailable	3 / 2
2026-08-21	Unavailable	Unavailable	3 / 2
2026-08-22	Unavailable	Unavailable	3 / 2
2026-08-23	Unavailable	Unavailable	3 / 2
2026-08-24	Unavailable	Unavailable	3 / 2
2026-08-25	Unavailable	Unavailable	3 / 2
2026-08-26	Unavailable	Unavailable	3 / 2
2026-08-27	Unavailable	Unavailable	3 / 2
2026-08-28	Unavailable	Unavailable	3 / 2
2026-08-29	Unavailable	Unavailable	3 / 2
2026-08-30	Unavailable	Unavailable	3 / 2
2026-08-31	Unavailable	Unavailable	3 / 2
2026-09-01	Unavailable	Unavailable	3 / 2
2026-09-02	Unavailable	Unavailable	3 / 2
2026-09-03	Unavailable	Unavailable	3 / 2
2026-09-04	Unavailable	Unavailable	3 / 2
2026-09-05	Unavailable	Unavailable	3 / 2
2026-09-06	Unavailable	Unavailable	3 / 2
2026-09-07	Unavailable	Unavailable	3 / 2
2026-09-08	Unavailable	Unavailable	3 / 2
2026-09-09	Unavailable	Unavailable	3 / 2
2026-09-10	Unavailable	Unavailable	3 / 2
2026-09-11	Unavailable	Unavailable	3 / 2
2026-09-12	Unavailable	Unavailable	3 / 2
2026-09-13	Unavailable	Unavailable	3 / 2
2026-09-14	Unavailable	Unavailable	3 / 2
2026-09-15	Unavailable	Unavailable	3 / 2
2026-09-16	Unavailable	Unavailable	3 / 2
2026-09-17	Unavailable	Unavailable	4 / 2
2026-09-18	Unavailable	Unavailable	4 / 2
2026-09-19	Unavailable	Unavailable	4 / 2
2026-09-20	Unavailable	Unavailable	4 / 2
2026-09-21	Unavailable	Unavailable	4 / 2
2026-09-22	Unavailable	Unavailable	4 / 2
2026-09-23	Unavailable	Unavailable	4 / 2
2026-09-24	Unavailable	Unavailable	4 / 2
2026-09-25	Unavailable	Unavailable	4 / 2
2026-09-26	Unavailable	Unavailable	4 / 3
2026-09-27	Unavailable	Unavailable	4 / 3
2026-09-28	Unavailable	Unavailable	4 / 3
2026-09-29	Unavailable	Unavailable	4 / 3
2026-09-30	Unavailable	Unavailable	4 / 3
2026-10-01	Unavailable	Unavailable	4 / 3
2026-10-02	Unavailable	Unavailable	4 / 3
2026-10-03	Unavailable	Unavailable	4 / 3
2026-10-04	Unavailable	Unavailable	4 / 3
2026-10-05	Unavailable	Unavailable	4 / 3
2026-10-06	Unavailable	Unavailable	4 / 3
2026-10-07	Unavailable	Unavailable	4 / 3
2026-10-08	Unavailable	Unavailable	4 / 3
2026-10-09	Unavailable	Unavailable	4 / 3
2026-10-10	Unavailable	Unavailable	4 / 3
2026-10-11	Unavailable	Unavailable	4 / 3
2026-10-12	Unavailable	Unavailable	4 / 3
2026-10-13	Unavailable	Unavailable	4 / 3
2026-10-14	Unavailable	Unavailable	4 / 3
2026-10-15	Unavailable	Unavailable	4 / 3
2026-10-16	Unavailable	Unavailable	4 / 3
2026-10-17	Unavailable	Unavailable	4 / 3
2026-10-18	Unavailable	Unavailable	4 / 3
2026-10-19	Unavailable	Unavailable	4 / 3
2026-10-20	Unavailable	Unavailable	4 / 3
2026-10-21	Unavailable	Unavailable	4 / 3
2026-10-22	Unavailable	Unavailable	4 / 3
2026-10-23	Unavailable	Unavailable	4 / 3
2026-10-24	Unavailable	Unavailable	4 / 3

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	1	3
2026-06-01	1	3
2026-07-01	1	3
2026-08-01	1	3
2026-09-01	1	4
2026-10-01	1	4

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 1 Buy / Strong Buy · 4 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Maintain quarterly dividend at $0.42 per shareDividend per share: $0.42 per share
Achieve EPS of at least $4.39 in 2026Diluted EPS: $1.35 per share
Limit revenue decline to no worse than -5% in next 12 monthsDirect metric needs a verified mapping
Complete share buyback of up to 850,000 shares (~5% of shares)Required source inputs unavailable

Next proof point

Oct 27, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

0.7%Typical daily move · historical

Downside history

-11.3%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Camden National Corp. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

CAC is a financial-sector growth and income business, with recent results supporting a multi-year growth thesis. The thesis is intact, but earnings quality is fragile and management execution is neutral overall.

What's priced into Camden National Corp.

Valuation is tagged as stretched, and CAC carries an 11% premium versus peers. Expectations are somewhat above the model’s baseline, though the gap is modest; the valuation measure has recently eased, and the evidence does not point to unusually concentrated fragility.

What the fundamentals likely do

Near-term results have been strong: loans, revenue, and net income rose from Q1 to Q2 2026, and the July earnings update was positive. Management is on track with growth and repurchases, while the quarterly dividend has been consistent but its status is mixed. Near-term miss risk is described as low, but weaker peer results and CAC’s smaller size remain watch points.

What Camden National Corp. hinges on

The multi-year view depends on sustained growth and disciplined execution, alongside earnings quality that becomes less fragile. In the near term, a guidance cut would be a meaningful negative, while continued earnings strength from sector bellwethers could support sector momentum. The rate backdrop is another swing factor: the evidence says rate cuts could weigh on financial stocks.